NRx Builds Momentum From FDA Progress To Strategic Expansion

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

Genes, brain chemicals to lifestyle and personality – what causes depression?

The traditional “ monoamine hypothesis ” of depression was proposed more than half a century ago, in the 1950s. This theory ...